• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Chief Financial Officer Broderick Christopher

    8/15/25 5:10:50 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $ATLN alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
    X
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Broderick Christopher

    (Last) (First) (Middle)
    270 SYLVAN AVENUE
    SUITE 2230

    (Street)
    ENGLEWOOD CLIFFS NJ 07632

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    ATLANTIC INTERNATIONAL CORP. [ ATLN ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Financial Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    08/15/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units(1) $0.0001 08/15/2025 08/15/2025 D 577,171 01/07/2026 07/07/2030 Common Stock 577,171 $0 0 D
    Explanation of Responses:
    1. These restricted stock units were returned to the issuer in an exempt transition pursuant to Rule 16b-3(e) of the Securities Exchange Act of 1934, upon the retirement of Christopher Broderick from the Company on August 15, 2025.
    /s/ Christopher Broderick 08/15/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ATLN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATLN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ATLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Financial Officer Broderick Christopher

    4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    8/15/25 5:10:50 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 4 filed by General Counsel Tenore Michael

    4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    8/13/25 4:46:32 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Chief Executive Officer Jagid Jeffrey M gifted 400,000 shares, decreasing direct ownership by 11% to 3,335,169 units (SEC Form 4)

    4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    8/13/25 4:45:41 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ATLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Financial Officer Broderick Christopher bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 40% to 2,004,237 units (SEC Form 4)

    4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    6/25/25 5:11:34 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: Chief Executive Officer Jagid Jeffrey M bought $289 worth of shares (2,885,856 units at $0.00), increasing direct ownership by 340% to 3,735,169 units (SEC Form 4)

    4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    6/25/25 5:04:40 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: General Counsel Tenore Michael bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 136% to 1,001,634 units (SEC Form 4)

    4/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

    6/25/25 5:02:59 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ATLN
    SEC Filings

    View All

    SEC Form 424B3 filed by Atlantic International Corp.

    424B3 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    8/22/25 4:05:31 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SCHEDULE 13D/A filed by Atlantic International Corp.

    SCHEDULE 13D/A - ATLANTIC INTERNATIONAL CORP. (0001605888) (Subject)

    8/15/25 4:05:06 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form RW filed by Atlantic International Corp.

    RW - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

    7/14/25 4:05:04 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ATLN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Atlantic International Corp. to Present at the 2025 Gateway Conference on September 4

    ENGLEWOOD CLIFFS, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a rapidly expanding provider of workforce solutions and outsourced services, today announced that its CEO will present at the 2025 Annual Gateway Conference, one of the nation's premier investor events connecting high-growth companies with institutional investors, analysts, and capital markets professionals. The conference will take place September 4–5, 2025, at the Four Seasons Hotel in San Francisco, CA. Jeffrey Jagid, Atlantic International Corp.'s CEO, is scheduled to present on Thursday, September 4 at 9:00 a.m. Pacific Time (PT). The presentation will be webcast live and ava

    8/18/25 7:00:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Atlantic International Corp. Reports Strong Operational Improvements in Second Quarter 2025

    ENGLEWOOD CLIFFS, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a leading strategic staffing, outsourced services, and workforce solutions company, today announced financial results for the second quarter ended June 30, 2025, demonstrating significant operational improvements and a strengthened financial position. Second Quarter 2025 Highlights: Net loss narrowed by 81% to $10.7 million (or $0.20 per share), compared to a net loss of $54.9 million (or $1.96 per share) in Q2 2024Service revenue was $102.9 million, with permanent placement services up 17% year-over-year.Gross profit margin improved to 11.1%, reflecting pricing discipline and efficiency

    8/14/25 7:00:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Gateway Group Announces Preliminary Sponsors and Presenting Companies for 2025 Gateway Conference

    NEWPORT BEACH, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Gateway Group ("Gateway"), a leading financial communications and digital media advisory firm, today announced the initial sponsors and presenting companies confirmed for its annual Gateway Conference taking place at the Four Seasons Hotel in San Francisco on September 3rd and 4th. The conference is expected to host more than 300 institutional investors and analysts for two days of company presentations and curated one-on-one meetings with executives from high-growth public and private companies across the tech, AI, cleantech, consumer, financial services, and industrials sectors. "We appreciate the strong support from our sponsors

    7/30/25 8:30:00 AM ET
    $ACNT
    $AIRG
    $AKA
    Steel/Iron Ore
    Industrials
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $ATLN
    Financials

    Live finance-specific insights

    View All

    Atlantic International Corp. Reports Strong 2024 Results with Over $442 Million in Revenue; Over 10% Revenue Growth

    Company Completes First Quarter Publicly-Traded on Nasdaq Global Market under "ATLN" Announces Strategic Developments and Outlook; Targets $1 to $1.5 Billion Revenue from Both Organic Growth and M&A Initiatives in the Next 12 to 18 Months ENGLEWOOD CLIFFS, N.J., March 28, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. ("Atlantic" or the "Company") (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services and workforce solutions, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Key Financial Highlights: Q4 2024 Revenue: Revenue for the fourth quarter was $129.5 million, representing an 11.5% increase from $116.

    3/28/25 7:30:00 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ATLN
    Leadership Updates

    Live Leadership Updates

    View All

    Atlantic International Corp. Appoints Industry Veteran Matt Evelt as Chief Operating Officer to Lead Global Workforce Solutions Strategy

    ENGLEWOOD CLIFFS, N.J., June 02, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. (NASDAQ:ATLN), a premier provider of outsourced services, staffing, and workforce solutions, today announced the appointment of Matt Evelt as Chief Operating Officer (COO), effective immediately. Evelt brings more than two decades of leadership experience in workforce strategy, operational transformation, and international expansion. In his new role, he will oversee global operations, drive efficiency, and help scale Atlantic International's delivery of innovative, client-focused staffing and workforce solutions. Evelt most recently served as President – Americas at Airswift, where he successfully led

    6/2/25 1:05:49 PM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials